miR-30 a as Potential Therapeutic by Targeting TET 1 through Regulation of the Hydroxymethlation of Drp-1 Promoter in IPF

@inproceedings{Zhang2017miR30AA,
  title={miR-30 a as Potential Therapeutic by Targeting TET 1 through Regulation of the Hydroxymethlation of Drp-1 Promoter in IPF},
  author={Songzi Zhang and Huizhu Liu and Yuxia Liu and Jie Ming Zhang and Hongbo Li and Weili Liu and Guohong Cao and Pan Xv and Jin-jin Zhang and Chang-jun Lv and Xiaodong Song},
  year={2017}
}
Several recent studies have indicated that miR-30a plays critical roles in various biological processes and diseases. However, the mechanism of miR-30a participation in the regulation of idiopathic pulmonary fibrosis (IPF) is ambiguous. Our previous study demonstrated that miR-30a may function as a novel therapeutic target for lung fibrosis by blocking… CONTINUE READING